TAAR1: What Is the Role of TAAR1 Agonism for the Treatment of Schizophrenia?

Поділитися
Вставка
  • Опубліковано 30 вер 2024
  • Dr. Jonathan M. Meyer of UC San Diego talks about TAAR1 agonism used in schizophrenia treatment.
    This video is part of a larger CE/CME Certified program entitled: Schizophrenia: A Promising Treatment Era Dawns. You can receive free CME credit, view this video, and download slides from the presentation at www.mededonthe...

КОМЕНТАРІ • 5

  • @patrickm1666
    @patrickm1666 2 місяці тому

    Can they try again phase 3 clinical trials for ulotaront? Seems so promising.

  • @JeffreyJorge-p1p
    @JeffreyJorge-p1p 8 місяців тому

    What about the negative symptoms of schizophrenia

  • @CharlieMikeRomeo
    @CharlieMikeRomeo 5 місяців тому

    Not only did Ulotaront not separate from placebo in phase 3, but asenapine also acts as a TAAR1 agonist already!

  • @peterweiden6578
    @peterweiden6578 Рік тому +2

    wonderful presentation, thank you !!

  • @entertainmenteducavlogs9717

    When will this medicine come in market?